Shay Capital’s Achieve Life Sciences ACHV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $661K | Buy |
292,647
+26,913
| +10% | +$60.8K | 0.08% | 115 |
|
|
2025
Q1 | $710K | Buy |
265,734
+240,734
| +963% | +$643K | 0.1% | 75 |
|
|
2024
Q4 | $88K | Sell |
25,000
-425,000
| -94% | -$1.5M | 0.01% | 221 |
|
|
2024
Q3 | $2.13M | Hold |
450,000
| – | – | 0.3% | 31 |
|
|
2024
Q2 | $2.12M | Hold |
450,000
| – | – | 0.29% | 46 |
|
|
2024
Q1 | $2.05M | Sell |
450,000
-275,000
| -38% | -$1.25M | 0.32% | 34 |
|
|
2023
Q4 | $2.99M | Sell |
725,000
-16,000
| -2% | -$65.9K | 0.6% | 23 |
|
|
2023
Q3 | $3.19M | Sell |
741,000
-35,600
| -5% | -$153K | 0.45% | 26 |
|
|
2023
Q2 | $4.03M | Buy |
776,600
+296,600
| +62% | +$1.54M | 0.56% | 16 |
|
|
2023
Q1 | $3.26M | Buy |
480,000
+140,000
| +41% | +$952K | 0.64% | 14 |
|
|
2022
Q4 | $833K | Hold |
340,000
| – | – | 0.26% | 51 |
|
|
2022
Q3 | $1.12M | Sell |
340,000
-55,759
| -14% | -$184K | 0.24% | 53 |
|
|
2022
Q2 | $1.93M | Sell |
395,759
-5,609
| -1% | -$27.4K | 0.39% | 19 |
|
|
2022
Q1 | $3.04M | Sell |
401,368
-4,349
| -1% | -$32.9K | 0.39% | 11 |
|
|
2021
Q4 | $3.16M | Buy |
405,717
+25,427
| +7% | +$198K | 0.52% | 14 |
|
|
2021
Q3 | $3.23M | Sell |
380,290
-22,785
| -6% | -$194K | 0.42% | 21 |
|
|
2021
Q2 | $3.62M | Buy |
403,075
+268,075
| +199% | +$2.41M | 0.42% | 21 |
|
|
2021
Q1 | $1.56M | Buy |
+135,000
| New | +$1.56M | 0.16% | 67 |
|